Radionuclide Therapy with Bone Seeking Radionuclides in Palliation of Painful Bone Metastases

Journal of Experimental and Clinical Cancer Research

Volumn 22, Issue 4 SUPPL., 2003, Pages 71-74

  Maini, C L ^a,b   Sciuto, R ^a   Romano, L ^a   Bergomi, S ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b NONE   (Italy)

Author keywords

Bone pain; Bone seeking radioisotopes; Pain palliation; Radionuclide therapy

Indexed keywords

CISPLATIN; ETIDRONIC ACID RE 186; LEXIDRONAM SAMARIUM SM 153; PHOSPHORUS 32; RADIOISOTOPE; STRONTIUM 89;

BONE METASTASIS; CANCER PAIN; CANCER PALLIATIVE THERAPY; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; DRUG INDICATION; DRUG SELECTIVITY; EVIDENCE BASED MEDICINE; HUMAN; NUCLEAR MEDICINE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER; RADIOISOTOPE THERAPY;

BONE NEOPLASMS; ETIDRONIC ACID; HUMANS; ORGANOMETALLIC COMPOUNDS; ORGANOPHOSPHORUS COMPOUNDS; PAIN; PALLIATIVE CARE; STRONTIUM;

EID: 1842583328     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. Bonica J.J.: Importance of effective pain control. Acta. Anesthesiol. Suppl. 85: 1-16, 1987
2. Morris M.J., Scher H.I.: Clinical approaches to osseous metastases in prostate cancer. The Oncologist. 8: 161-173, 2003.
3. Hamdy N.A.T., Papapoulos S.E.: The palliative management of skeletal metastases in prostate cancer: use of bone seeking radionuclides and biphophonates. Sem. Nuc. Med. 1: 62-69, 2001.
4. Piga A., Bracci R., Ferretti B., et al.: A double blind randomized study of oral clodronate in the treatment of bone metastases from tumours poorly responsive to chemotherapy. J. Exp. Clin. Cancer Res. 17: 213-217, 1998.
5. Pistevou-Gombaki K., Eleftherias N., Sofroniadis I., Makris P., Koulias V.: Palliative treatment of painful bone metastases from non-Hodgkin lymphoma with disodium pamidronate. J. Exp. Clin. Cancer Res. 2: 429-432, 2002.
6. Lewington V.J.: Targeted radionuclide therapy for bone metastases. Eur. J. Nuc. Med. 20: 66-74, 1993.
7. Mc Ewan A.J.B.: Unsealed source therapy of painful bone metastases. An update. Sem. Nuc. Med. 26: 185-192, 1997.
8. Quilty P.M., Kirk D. Bolger J.J. et al.: A comparison of the palliative effect of Strontium-89 and external beam radiotherapyin metastatic prostate cancer. Radiother. Oncol. 31: 33-40, 1994.
9. Sciuto R., Festa A., Rea S. et al.: Effects of low-dose cisplatin on 89Sr therapy for painful bone metastases from prostate cancer: a randomized clinical trial. J. Nucl. Med. 43: 79-86, 2002.
10. Sciuto R., Tofani A., Festa A., Giannarelli D., Pasqualoni R., Maini C.L.: Short and long term Effects of 186 Re hydroxyethylidene diphophonate in the treatment of painful bone metastases. J. Nucl. Med. 41: 647-654, 2000.
11. Laing A.H., Ackery D.M., Bayly R.J. et al.: Strontium-89 chloride for pain palliation in prostatic skeletal malignancy. Br. J. Radiol. 64: 816-822, 1991.
12. Collins C., Eary J.F., Donaldson G. et al.: Samarium-153-EDTMP in bone metastases of hormone refractory prostate carcinoma: a phase I/II trial. J. Nucl. Med. 34: 1839-1844, 1993.
13. de Klerk J.M.H., van het Ship A.D., Zonnemberg B.A. et al.: Phase I study of rhenium-186 HEDP in patients with bone metastases originating from breast cancer. J. Nucl. Med. 37: 244-248, 1996.
14. Mc Ewan A.J.B, Amyone G.A., McGowan D.G. et al.: A retrospective analysis of the cost-effectiveness of treatment with Metastron (89Sr-chloride) in patients with prostate cancer metastatic to bone. Nuc.med. Comm. 15: 499-504, 1994.
15. Sciuto R., Festa A., Pasqualoni R. et al.: Metastatic Bone pain palliation with 89-Sr and 186-re-HEDP in breast cancer patients. Breast. Cancer. Res. Treat. 66: 101-109, 2001.
16. Smith M., Kantoff P, Talcott J. Clinical Evidence Edizione Italiana: Ed. Zadlig, Milan, 119-120, 2003.
17. Sciuto R., Maini C.L., Tofani A., Fiumara C., Scelsa M.G.: Broccatelli M. Radiosensitization with low-dose carboplatin enhances pain palliation in radioisotope therapy with strontium-89. Nuc. Med. Comm. 17: 799-804, 1996.
18. Sciuto R., Festa A., Tofani A. et al.: Platinum compound as radiosensitizers in strontium-89 metabolic radiotherapy. Clin. Ter. 149: 43-47, 1998.
19. Mc Ewan A.J.B.: Radioisotope therapy and clinical trial. The need for consensus and innovation. J. Nuc. Med. 43: 87-88, 2002.
20. McCready V.R., O'Sullivan J.M.: Future directions for unsealed source radionuclide therapy for bone metastases. Eur. J. Nuc. Med. 29: 1271-1275, 2002.